The trademark application RYSANSO was filed by Lykos Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on March 21, 2024, and it was registered by office on June 28, 2024 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations
Psychotherapeutic preparations
Pharmaceutical preparations for the treatment and management of psychiatric, psychological, and neurological disorders
Therapeutic agents for treating and managing PTSD, eating disorders, postpartum depression, alcohol use disorder, opioid and substance use disorder, generalized anxiety disorder, social anxiety disorder, major depressive disorder, and traumatic brain injury
Medicaments to help assist with treatment and management of psychiatric, psychological, and neurological disorders.